Ljubimova. Cancer Res 71:1454-1464 February 2011 DOI: 10.1158/0008-5472.CAN-10-3093.. Ljubimova and two fellow researchers have declared a financial interest in a company that has an interest in this technology.Funds for the current study came from the National Institutes of Health, the Winnick Family Foundation, and the Department of Neurosurgery at Cedars-Sinai Medical Center.Support for future studies of the nanoconjugate at Cedars-Sinai nanomedicine research laboratory includes a five-year grant from the National Cancer Institute as part of the Nanotechnology in Cancer Program.
‘Our main achievement so far is that there is now a political agreement that prevention is an important issue,’says Professor Perk, ‘but there are still huge variety as each country in Europe turn words into action, some countries.B treatment to to toxicity reduced directly to zebra fish by inhibiting NF-kappa – B, A Key Inflammatory Protein inhibition of activity of a protein key mediator of inflammation decreases radiant toxicity in zebrafish embryos , and can ultimately aim to help patient on have receiving radiation therapy, the opinion of the researchers from the Kimmel Cancer Center in the Jeffersonville.
Doc Rodeck and Thicker will move those research forward finally ultimately assist individual subjected ‘dirty bombs’or the cancer patients receiving radiotherapy. Your research team is pioneer with zebrafish a vertebrates models system of to investigate the effects radiotherapy.